Barrett & Company’s Kyndryl KD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.58K Buy
407
+10
+3% +$127 ﹤0.01% 539
2026
Q2
$4.49K Buy
397
+96
+32% +$1.2K ﹤0.01% 561
2026
Q1
$3.95K Hold
301
– – ﹤0.01% 541
2025
Q4
$7.99K Hold
301
– – ﹤0.01% 487
2025
Q3
$9.04K Sell
301
-14
-4% -$481 ﹤0.01% 476
2025
Q2
$13.2K Sell
315
-132
-30% -$4.77K 0.01% 452
2025
Q1
$14K Buy
447
+103
+30% +$3.86K 0.01% 417
2024
Q4
$11.9K Sell
344
-56
-14% -$1.63K 0.01% 423
2024
Q3
$9.19K Hold
400
– – ﹤0.01% 431
2024
Q2
$10.5K Sell
400
-216
-35% -$5.18K ﹤0.01% 426
2024
Q1
$13.4K Buy
616
+200
+48% +$4.25K 0.01% 413
2023
Q4
$8.64K Hold
416
– – ﹤0.01% 424
2023
Q3
$6.28K Hold
416
– – ﹤0.01% 461
2023
Q2
$5.52K Sell
416
-5
-1% -$68 ﹤0.01% 464
2023
Q1
$6.21K Sell
421
-15
-3% -$213 ﹤0.01% 429
2022
Q4
$4.85K Hold
436
– – ﹤0.01% 450
2022
Q3
$4.85K Buy
+436
New +$4.54K ﹤0.01% 450

Other funds holding KD

Barrett & Company's KD Position: Q3 2026 in Review

Barrett & Company increased its Kyndryl (KD) stake by 2.5% in Q3 2026, buying an estimated $127 and bringing the position to 407 shares worth $4.58K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Barrett & Company first reported a position in KD in Q3 2022 and has held it in 17 quarters since. The position peaked at $14K in Q1 2025. 642 funds tracked by Wall St. Rank hold KD as of Q3 2026.

  • Barrett & Company held 407 shares of Kyndryl worth $4.58K as of Q3 2026.
  • Barrett & Company bought 10 Kyndryl shares in Q3 2026, an estimated $127.
  • Kyndryl made up ﹤0.01% of Barrett & Company's portfolio in Q3 2026, its #539 holding.
  • Barrett & Company first reported a position in Kyndryl in Q3 2022 and has held it in 17 quarters since.
  • Barrett & Company's Kyndryl position peaked at $14K in Q1 2025.
  • 642 funds tracked by Wall St. Rank held Kyndryl as of Q3 2026.

Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.